Key Takeaways
- Walmart (WMT) beat Q1 revenue expectations with $177.75 billion and reported strong 4.1% U.S. comparable sales growth, though full-year guidance remains slightly below analyst estimates.
- Eli Lilly (LLY) shares significant Phase 3 trial data for Retatrutide, showing an average weight loss of 30.3% after 104 weeks for patients on the 12 mg dose.
- Ford (F) restructured its battery plant obligations, terminating a $6.6 billion capital contribution requirement and taking on a $3.81 billion promissory note to the Department of Energy.
- The European Union is reportedly seeking a carve-out for banned Chinese semiconductor chips to prevent supply chain disruptions within the critical automotive industry.
- Geopolitical tensions remain high as reports indicate Iran’s Supreme Leader has ordered that near-weapons-grade uranium must remain within the country.
Walmart Reports Strong Top-Line Growth Amid Fuel Headwinds
Walmart (WMT) kicked off the retail earnings season with a robust Q1 2026 performance, reporting revenue of $177.75 billion, surpassing the consensus estimate of $175.06 billion. The retail giant saw U.S. comparable store sales (excluding gas) rise 4.1%, beating the 4% growth anticipated by analysts. Adjusted earnings per share (EPS) came in at $0.66, exactly in line with market expectations.
Despite the revenue beat, the company’s outlook for the remainder of the year appeared conservative. Walmart (WMT) projects FY Adj. EPS between $2.75 and $2.85, which sits below the analyst estimate of $2.92. Management noted that operating income was negatively affected by 250 basis points due to higher fuel costs within its distribution and fulfillment networks.
Eli Lilly’s Retatrutide Shows Unprecedented Weight Loss Results
Eli Lilly (LLY) released highly anticipated data from its TRIUMPH-1 Phase 3 obesity trial for Retatrutide. The study revealed that 45.3% of patients taking the 12 mg dose lost at least 30% of their body weight after 80 weeks. By the 104-week mark, the average weight loss for the 12 mg group reached a staggering 30.3%.
The safety profile of the drug also remained a focal point for investors. The 4 mg dose of Retatrutide showed a low 4.1% discontinuation rate due to adverse events, which was actually lower than the 4.9% rate observed in the placebo group. These results solidify Eli Lilly (LLY)'s position as a dominant force in the rapidly expanding GLP-1 and multi-agonist weight loss market.
Ford Restructures Battery Strategy and Debt Obligations
In a series of SEC filings, Ford (F) announced a significant shift in its electric vehicle supply chain financing. The automaker is no longer bound by the sponsor support and share retention agreements previously in place and has terminated a $6.6 billion capital contribution requirement to BOSK.
Simultaneously, Ford Energy Battery LLC has acquired BOSK’s stake in two battery plants located in Kentucky. To facilitate this transition, Ford (F) has committed to a $3.81 billion promissory note to the U.S. Department of Energy (DOE) specifically for the Kentucky factory operations.
EU Seeks Semiconductor Carve-Out for Automotive Sector
The European Union is reportedly negotiating an exception for banned Chinese chips to shield its domestic automotive industry from further production delays. The move highlights the ongoing struggle between Western trade restrictions and the practical realities of highly integrated global supply chains.
In other industrial news, Advanced Drainage Systems (WMS) released its FY outlook, projecting Adjusted EBITDA between $1.00 billion and $1.05 billion. The company’s Q4 sales of $676.76 million beat the estimated $649.2 million, signaling continued demand in the construction and infrastructure sectors.
Energy and Geopolitical Developments
QatarEnergy continues its aggressive expansion, signing a Memorandum of Understanding (MOU) with the Egyptian government and ExxonMobil (XOM) to explore gas findings in the Eastern Mediterranean. The state-owned firm also entered an agreement to explore potential gas developments in Cyprus, further cementing its role in regional energy security.
On the geopolitical front, reports from senior Iranian sources suggest that Iran's Supreme Leader has issued a directive to keep near-weapons-grade uranium within the country, reflecting a firm consensus among the Iranian establishment. Meanwhile, the Kremlin dismissed reports that Russian forces were being covertly trained by China as "false," following high-level discussions between Vladimir Putin and Xi Jinping regarding peace efforts in Ukraine.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.